Back

Safety and efficacy of the use of intravenous flecainide in the context of an aggressive rhythm control strategy in patients with atrial fibrillation in the emergency department (HEROMEDICUS study)

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Tools and strategies in atrial fibrillation rhythm control Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Nikolaos Argyriou

National & Kapodistrian University of Athens Medical School, Athens (Greece)

5 More presentations in this session

Presentation thumbnail
Invasive left atrial pressure at transseptal puncture correlates with proBNP but adds limited prognostic information
Mr E. Heil (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Identification of pulmonary vein triggers during de novo catheter ablation for atrial fibrillation predicts better clinical outcomes
Doctor Y. Choi (Seoul, KR)
Abstract Slides
Presentation thumbnail
Impact of esophageal cooling versus temperature monitoring on safety and procedural parameters during radiofrequency ablation of atrial fibrillation: A single-center experience in Germany
Professor D. Grosse Meininghaus (Cottbus, DE)
Abstract Slides Video
Presentation thumbnail
Fastest pulmonary vein atrial fibrillation cycle length Identifies PVI responders beyond clinical atrial fibrillation pattern: the FARS-AF II study
Doctor L. Marcon (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Impact of energy source for pulmonary vein isolation on heart rate variability and autonomic modulation
Doctor A. Karanikola (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Tools and strategies in atrial fibrillation rhythm control

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Safety and efficacy of electrical cardioversion of atrial fibrillation in the emergency department (HEROMEDICUS study)
thumbnail
Congress Presentation
An aggressive electrophysiologist-guided rhythm control strategy significantly reduces hospital admissions in patients presenting with atrial fibrillation in the emergency department.
thumbnail
Congress Presentation
An aggressive electrophysiologist-guided rhythm control strategy significantly reduces hospital admissions in patients presenting with atrial fibrillation in the emergency department. Data from the HE

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources